graph Evidence gap map comparisons
atezolizumab based treatmentavelumab based treatmentanti-PD-(L)1Immune checkpoint association
atezolizumab plus bevacizumab plus carboplatin plus paclitaxel atezolizumab plus SoC avelumab alone avelumab plus pegylated liposomal doxorubicin avelumab plus SoC nivolumab based treatment nivolumab plus ipilimumab
Comparator:  vs bevacizumab plus carboplatin and paclitaxel;   vs pegylated liposomal doxorubicin;   vs nivolumab alone;   vs Standard of Care (SoC);   vs rucaparib;   vs placebo plus SoC; 
Risk of bias:  low;   some concerns;   high;  NA;